Funding · Healthcare & Life Sciences

Biopeak raises $2.7M from Nikhil Kamath

By Startup Enthusiast · 2 February 2026

What they do

Biopeak is India's first longevity and health optimisation brand, offering multidisciplinary specialist-led programs

It raised $2.7M (₹24.8 Cr) in a round led by existing investor Nikhil Kamath through NKSquared

The funds will be used to expand diagnostics, AI capabilities, launch a new Bengaluru centre, and grow the team

Biopeak raised $2.7M (₹24.8 Cr) in its latest funding round.
The round was led by Nikhil Kamath through NKSquared, who is also an existing investor.
The company plans to use the funds to expand presence and deepen capabilities across diagnostics, proprietary AI, research, and program development.
It will launch a new flagship centre in Bengaluru.
The team will be expanded across clinical, research, product, and operations roles.
Biopeak will also strengthen its network of global advisors and institutional partners for protocol development and clinical governance.

Longevity and precision healthcare are gaining focus globally and in India.
Biopeak's approach is designed around Indian health profiles and disease patterns.
It collaborates with IISc and Longevity India to contextualise healthspan data for South Asian genetics, environment, and lifestyle.

Biopeak is India's first longevity and health optimisation brand.
It offers multidisciplinary specialist-led programs combining diagnostics, proprietary AI-driven insights, targeted clinical interventions, and sustained follow-up.
The technology profiles 130+ biomarker blood panels, genetic/epigenetic profiling, gut/oral microbiome mapping, hormonal analysis, salivary cortisol rhythms, and whole-exome functional genomics, paired with MRI, CT, DXA, ECHO, and Carotid IMT imaging.
Its primary customer base is young professionals and affluent individuals, particularly women.
It has specialised modules for women covering health, skin and gut longevity, and advanced imaging for silent degeneration.
The team includes doctors, nutritionists, physiologists, and mental health experts.
Biopeak's proprietary system is the Longevity Hexacode, a six-layer system.

Expand presence and deepen capabilities across diagnostics, proprietary AI, research, and program development.
Launch a new flagship centre in Bengaluru.
Expand team across clinical, research, product, and operations.
Strengthen network of global advisors and institutional partners for protocol development and clinical governance.

Nikhil Kamath (lead) — Existing investor in Biopeak; invested through NKSquared.

Product: Longevity-focused health clinics and personalized preventive care programs
Customers: Individuals and families seeking preventive, long-term health optimization
How it makes money: Clinic-based services and diagnostic-led health programs
What sets it apart: Combines cellular and molecular diagnostics, imaging and AI-driven insights
Operations: Expanding clinic operations in Bengaluru and other Indian cities